BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27416001)

  • 21. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema.
    Warner KK; Visconti JA; Tschampel MM
    Ann Pharmacother; 2000 Apr; 34(4):526-8. PubMed ID: 10772441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDA turns to electronic "sentinel" to flag prescription drug safety problems.
    Kuehn BM
    JAMA; 2008 Jul; 300(2):156-7. PubMed ID: 18612108
    [No Abstract]   [Full Text] [Related]  

  • 23. Antihypertensive drug associated angioedema: effect modification by race/ethnicity.
    Reichman ME; Wernecke M; Graham DJ; Liao J; Yap J; Chillarige Y; Southworth MR; Keeton S; Goulding MR; Mott K; Kelman JA
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1190-1196. PubMed ID: 28722207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of exposure accrual on sequential postmarket evaluations: a simulation study.
    Maro JC; Brown JS
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1184-91. PubMed ID: 22020903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-converting enzyme inhibitor-induced angioedema.
    Bezalel S; Mahlab-Guri K; Asher I; Werner B; Sthoeger ZM
    Am J Med; 2015 Feb; 128(2):120-5. PubMed ID: 25058867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment.
    Cicardi M; Zingale LC; Bergamaschini L; Agostoni A
    Arch Intern Med; 2004 Apr; 164(8):910-3. PubMed ID: 15111379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Miscategorization of Deaths in the US Food and Drug Administration Adverse Events Database.
    Meier L; Wang EY; Tomes M; Redberg RF
    JAMA Intern Med; 2020 Jan; 180(1):147-148. PubMed ID: 31589249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative Performance of Propensity Score Matching Strategies for Subgroup Analyses.
    Wang SV; Jin Y; Fireman B; Gruber S; He M; Wyss R; Shin H; Ma Y; Keeton S; Karami S; Major JM; Schneeweiss S; Gagne JJ
    Am J Epidemiol; 2018 Aug; 187(8):1799-1807. PubMed ID: 29554199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema.
    Pylypchuk GB
    Ann Pharmacother; 1998 Oct; 32(10):1060-6. PubMed ID: 9793599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Iatrogenic angioedema: the role of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers].
    Roskiewicz F; Andriamanana I; Gras-Champel V; Andrejak M; Massy ZA
    Nephrol Ther; 2007 Jun; 3(3):89-95. PubMed ID: 17540310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precipitation of angioedema by antihypertensive drugs.
    Hedner T; Samuelsson O; Lindholm L; Andrén L; Wiholm BE
    J Hypertens Suppl; 1991 Dec; 9(6):S360-1. PubMed ID: 1687873
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug safety in Aboriginal Australians: three cases of angiotensin-converting enzyme inhibitor angioedema.
    Mahajan H; Thynne T; Gabb GM; Poh EW
    Intern Med J; 2015 Feb; 45(2):231-3. PubMed ID: 25650541
    [No Abstract]   [Full Text] [Related]  

  • 33. Angiotensin-converting enzyme inhibitor-associated angioedema.
    Byrd JB; Adam A; Brown NJ
    Immunol Allergy Clin North Am; 2006 Nov; 26(4):725-37. PubMed ID: 17085287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse Events Involving Radiation Oncology Medical Devices: Comprehensive Analysis of US Food and Drug Administration Data, 1991 to 2015.
    Connor MJ; Marshall DC; Moiseenko V; Moore K; Cervino L; Atwood T; Sanghvi P; Mundt AJ; Pawlicki T; Recht A; Hattangadi-Gluth JA
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):18-26. PubMed ID: 27979446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department.
    Bluestein HM; Hoover TA; Banerji AS; Camargo CA; Reshef A; Herscu P
    Ann Allergy Asthma Immunol; 2009 Dec; 103(6):502-7. PubMed ID: 20084844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of angiotensin-converting enzyme inhibitor-related angioedema: recommendations from the French National Center for Angioedema].
    Nosbaum A; Bouillet L; Floccard B; Javaud N; Launay D; Boccon-Gibod I; Fain O; ;
    Rev Med Interne; 2013 Apr; 34(4):209-13. PubMed ID: 23380506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting enzyme inhibitor-induced angioedema.
    Theyab AA; Lee DS; Khachemoune A
    Cutis; 2013 Jan; 91(1):30-5. PubMed ID: 23461056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent.
    Fireman B; Toh S; Butler MG; Go AS; Joffe HV; Graham DJ; Nelson JC; Daniel GW; Selby JV
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():282-90. PubMed ID: 22262618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common Models, Different Approaches.
    Gagne JJ
    Drug Saf; 2015 Aug; 38(8):683-6. PubMed ID: 26088718
    [No Abstract]   [Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibitor-induced unilateral tongue angioedema.
    Kuhlen JL; Forcucci J
    Am J Med Sci; 2012 Nov; 344(5):416-7. PubMed ID: 22986608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.